Bridging the gap between Longevity science and clinicians

Latest articles

The Alliance for Longevity Initiatives – fighting aging

Advancing legislation and policies that aim to increase healthy human lifespan. Longevity is a journey that would be good to imagine we're all taking together;...

Team builds first living robots – that can reproduce

AI-designed Xenobots reveal entirely new form of biological self-replication which could prove promising for regenerative medicine. Birds do it, bees do it... now even living...

Aging in place trailblazer focus – Carewell

Carewell – aiding individuals through their caregiving journey with empathy and knowledge. Over the coming weeks, we will be bringing you extracts from 7 trailblazer...

Humanpeople raising £700k for AI preventative health platform

Digital preventative health platform combines blood, DNA and microbiome testing to power up your healthspan with highly personalised supplements. DISCLOSURE: Longevity.Technology (a brand of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

The Alliance for Longevity Initiatives – fighting aging

Advancing legislation and policies that aim to increase healthy human lifespan. Longevity is a journey that would be good to imagine we're all taking together;...

Team builds first living robots – that can reproduce

AI-designed Xenobots reveal entirely new form of biological self-replication which could prove promising for regenerative medicine. Birds do it, bees do it... now even living...

Aging in place trailblazer focus – Carewell

Carewell – aiding individuals through their caregiving journey with empathy and knowledge. Over the coming weeks, we will be bringing you extracts from 7 trailblazer...

Click the globe for translations.

Deep Longevity continues to build its life-extension ecosystem with a new structured course on Longevity medicine.

Deep Longevity, the Insilico spin-out which was acquired by Regent Pacific, has announced it is launching a First Introduction to Longevity Medicine for Physicians course on LabXchange Platform. The course seeks to provide a comprehensive Longevity medicine curriculum for clinicians, covering topics of bioregontology, geroscience and AI-based medicine.

Longevity.Technology: Aging is the greatest risk factor for most acute and chronic diseases, and although we are on the cusp of being able to intervene in the aging process to effectively decrease overall mortality and morbidity rates for an aging population, Longevity research is far ahead of medicine progress-wise. Deep Longevity’s new course aims to bridge this gap, bringing clinicians up to speed with recent advances in aging and Longevity interventions and bringing anti-aging out of the lab and into the clinic.

Deep Longevity has considerable experience in explainable AI systems and aging clocks that track aging rates on multiple levels. The new course which aims to fill the educational gap in translation longevity medicine will leverage this, covering a broad foundation of translational aging research terminology, theories and hallmarks of aging, basic aging pathways and mechanisms behind geroprotective interventions.

“As we are partnering with the advanced clinical institutions we see the gap between translational research and clinical practice and would like to provide the MDs with the resources they need to get into the rapidly growing field of longevity medicine, learn about the latest advances in artificial intelligence and in the pharmaceutical industry,” said Alex Zhavoronkov, PhD, the founder of the Longevity Medicine course and Chief Longevity Officer at Deep Longevity.

COVIDomic is an open access tool to stratify risk and severity from multimodal data sets ,including multi-omics data.
Alex Zhavoronkov, PhD, the founder of the Longevity Medicine course

Longevity Medicine for Physicians contains three hours of core lectures, as well as lecture slides and notes, quizzes, guest lectures and references to additional reading materials and online resources. It is intended to be the first course in a series that will aim to provide advanced physicians with the latest approaches in Longevity technology.

“While much-scattered information is available from more or less evidence-based sources, there was a lack of a structured, guided and well organised course that provides physicians with the necessary background information on this rapidly evolving discipline of healthy longevity. This is why we developed this very first course in Longevity Medicine – to close this gap and provide understandable and practicable, credible resources for clinicians,” said Evelyne Bischof, MD, co-founder of the course.

Evelyne Bischof, MD, co-founder of the course

Speaking to Longevity.Technology, Dr Bischof was enthusiastic about the new course.

“Longevity medicine will become the medicine of the future,” she told us. “And physicians are missing the train because we have so much other stuff to learn every single day. But if we don’t jump on the train right now to educate ourselves about it, then it will be too late. Having a course that is validated, credible, certified and approved by medical societies and bodies will hopefully help to change that.”

Our interview with Dr Evelyne Bischof will be published tomorrow – stay tuned!

Images courtesy of BoxerX / Shutterstock, Dr Bischof and Deep Longevity

1 COMMENT

Comments are closed.

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

Team builds first living robots – that can reproduce

AI-designed Xenobots reveal entirely new form of biological self-replication which could prove promising for regenerative medicine. Birds do it, bees do it... now even living...

Aging in place trailblazer focus – Carewell

Carewell – aiding individuals through their caregiving journey with empathy and knowledge. Over the coming weeks, we will be bringing you extracts from 7 trailblazer...

Humanpeople raising £700k for AI preventative health platform

Digital preventative health platform combines blood, DNA and microbiome testing to power up your healthspan with highly personalised supplements. DISCLOSURE: Longevity.Technology (a brand of...

A brain fitbit that can spot Alzheimer’s with up to 94% accuracy

Altoida raising new financing for augmented reality cognitive assessment platform that dramatically improves early detection of Alzheimer’s and other neurodegenerative diseases. Earlier this year, AR-powered...

Insilico starts human trial with AI-discovered drug

First human dosed with AI-discovered novel molecule based on an AI-discovered novel target. Insilico Medicine, an end-to-end artificial intelligence (AI)-driven drug discovery company, has announced that the...

    Subscribe to our newsletter